AMGEN LIMITED
Operating as the UK subsidiary of the global biotechnology group Amgen, the company focuses on the research, development, and commercialisation of biologic medicines for serious illnesses.
Get an alert when AMGEN LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
—
Latest balance sheet
Net assets
£134m
+0.6% highest in 3 filed years
Employees
728
+10.5% highest in 3 filed years
Profit before tax
£31m
+13.3% highest in 3 filed years
Net assets
3-year trend · vs Health Care median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £310,896,000 | £373,209,000 | £416,498,000 | +11.6% | |
| Operating profit | £18,935,000 | £22,965,000 | £25,226,000 | +9.8% | |
| Profit before tax | £22,769,000 | £27,309,000 | £30,939,000 | +13.3% | |
| Net profit | £16,474,000 | £17,945,000 | £21,352,000 | +19% | |
| Cash | — | — | — | — | |
| Total assets less current liabilities | — | £140,895,000 | £141,848,000 | +0.7% | |
| Net assets | £108,166,000 | £133,697,000 | £134,433,000 | +0.6% | |
| Equity | £108,166,000 | £133,697,000 | £134,433,000 | +0.6% | |
| Average employees | 592 | 659 | 728 | +10.5% | |
| Wages | £69,195,000 | £76,418,000 | £86,293,000 | +12.9% | |
| Directors' remuneration | £1,274,000 | £1,415,000 | £1,389,000 | -1.8% | |
| Directors' pension contributions | £61,000 | £133,000 | £130,000 | -2.3% | |
| Highest paid director | £502,000 | £502,000 | £467,000 | -7% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Operating margin | 6.1% | 6.2% | 6.1% | |
| Net margin | 5.3% | 4.8% | 5.1% | |
| Return on capital employed | — | 16.3% | 17.8% | |
| Gearing (liabilities / total assets) | — | 65.3% | 66.9% | |
| Current ratio | — | 1.53x | 1.49x | |
| Interest cover | 60.69x | 80.02x | 98.16x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 2 times since incorporation
- AMGEN LIMITED 1989-05-12 → present
- AMGEN (U.K.) LIMITED 1989-04-14 → 1989-05-12
- LAW 102 LIMITED 1989-03-01 → 1989-04-14
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Ernst & Young LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Accordingly, the directors do not believe there is a material uncertainty over the company's ability to continue as a going concern for a period until 31 July 2027 and continue to adopt the going concern basis in preparing their financial statements.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 34 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| HODGES, Sophie Jane | Secretary | 2014-09-22 | — | — |
| ABBERLEY, Russell James | Director | 2020-08-01 | Jan 1975 | British |
| FLOROU, Paraskevi | Director | 2023-02-20 | Nov 1979 | Greek |
| WALKER, Christopher Paul | Director | 2016-03-15 | Jul 1970 | British |
Show 34 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| CAMPBELL, Adrian Clemont | Secretary | 2007-07-16 | 2012-08-15 |
| MCINTOSH, Kyle Glenn | Secretary | 2012-08-15 | 2014-09-22 |
| HUNTSMOOR NOMINEES LIMITED | Corporate Nominee Secretary | — | 2007-07-16 |
| BEDSON, Simon David | Director | 2002-07-01 | 2005-12-31 |
| BINDER, Gordon | Director | — | 1996-10-31 |
| BROOM, Colin, Dr | Director | 2001-01-01 | 2002-12-31 |
| BROUWER, Aart | Director | — | 2001-12-31 |
| BYRNE, Gerald | Director | — | 1996-06-12 |
| CLAEYS, Justin Gary | Director | 2018-04-20 | 2020-08-01 |
| DITTRICH, Thomas Johannes Willi | Director | 2006-07-05 | 2010-08-30 |
| ELINOFF, Adam Stewart | Director | 2020-08-01 | 2023-01-31 |
| FOX, Christine Lee | Director | 2018-04-20 | 2020-08-01 |
| GUSTAFSON, Kurt Alfred | Director | 2004-06-21 | 2006-07-05 |
| HAIGH, Jeremy Rupert Michael | Director | 2003-01-01 | 2015-04-30 |
| HOFFMANN, Rolf Karl-Heinz | Director | 2004-11-01 | 2012-11-26 |
| KEARNEY, John Patrick | Director | 2007-09-03 | 2018-04-20 |
| KELLER, Joseph Kenneth | Director | 2005-12-31 | 2007-09-03 |
| KELLY, Michael Arron | Director | 2010-09-01 | 2013-05-31 |
| LEONARD JUNIOR, Keith Richard | Director | 2002-01-01 | 2004-10-29 |
| MCKINLAY, Christopher Ian | Director | 2013-05-31 | 2018-04-20 |
| MORRISON, Alan | Director | 2015-04-30 | 2015-07-10 |
| MORSTYN, George, Dr | Director | 2000-09-01 | 2001-12-31 |
| ODRE, Steven | Director | 2000-03-01 | 2001-12-31 |
| SEARS, Lowell | Director | — | 1993-04-01 |
| SHARER, Kevin W | Director | 1993-04-01 | 1998-12-10 |
| SHEARER, Margaret Louise | Director | 2001-03-15 | 2002-05-19 |
| SMITHER, John William | Director | 2002-01-01 | 2004-06-21 |
| STABITZ, Arthur | Director | — | 1992-09-15 |
| THIEL, Frank Carsten | Director | 2012-11-26 | 2014-08-31 |
| VAN DEN BROUCKE, Christiaan | Director | 2014-09-01 | 2014-09-01 |
| VANDEMAN, George A | Director | 1995-12-21 | 2000-03-01 |
| WEBB, Colin, Dr | Director | 1994-02-18 | 2000-12-31 |
| WORKMAN JR, Thomas E | Director | 1992-09-15 | 1995-12-21 |
| YOUNG, Kevin | Director | 1996-06-19 | 2001-03-14 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Amgen Inc. | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 217 total filings
Material constitutional events — rename, articles re-file, resolution
- 2025-02-03 RESOLUTIONS Resolution
- 2025-02-03 MA Memorandum articles
- 2025-01-31 CC04 Statement of companys objects
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-08-10 | AA | accounts | Accounts with accounts type full | |
| 2026-07-06 | TM01 | officers | Termination director company with name termination date | |
| 2026-06-17 | AP01 | officers | Appoint person director company with name date | |
| 2025-09-30 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-07-25 | AA | accounts | Accounts with accounts type full | |
| 2025-02-03 | RESOLUTIONS | resolution | Resolution | |
| 2025-02-03 | MA | incorporation | Memorandum articles | |
| 2025-01-31 | CC04 | change-of-constitution | Statement of companys objects | |
| 2024-10-14 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-07-17 | AA | accounts | Accounts with accounts type full | |
| 2023-10-05 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-09-21 | AA | accounts | Accounts with accounts type full | |
| 2023-03-07 | AP01 | officers | Appoint person director company with name date | |
| 2023-02-15 | TM01 | officers | Termination director company with name termination date | |
| 2022-10-04 | AA | accounts | Accounts with accounts type full | |
| 2022-09-30 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-10-12 | AA | accounts | Accounts with accounts type full | |
| 2021-10-12 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-09-06 | CH01 | officers | Change person director company with change date | |
| 2021-09-06 | CH01 | officers | Change person director company with change date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 3
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.